Description
Recombinant monoclonal antibody to CD16. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma DJ130c.
Target
CD16
Target Alias Names
CD16, Low affinity immunoglobulin gamma Fc region receptor III, Low affinity immunoglobulin gamma Fc region receptor III-A, Low affinity immunoglobulin gamma Fc region receptor III-B, CD16, CD16a, CD16b, FCGR3, FCGR3A, FCGR3B, Fc-gamma RIII-alpha, Fc-gamma RIII, Fc-gamma RIIIa, FcRIII, FcRIIIa, FcR-10, IgG Fc receptor III-2, Fc-gamma RIII-beta, Fc-gamma RIIIb, FcRIIIb
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression